Measuring Social Isolation, Loneliness, and Intersectional Stigma among Older Adults with Opioid Use Disorder

衡量患有阿片类药物使用障碍的老年人的社会孤立、孤独和交叉耻辱

• 批准号: 10683023
• 负责人: Benjamin Hyun Han
• 金额: $ 20.98万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-04-01 至 2025-03-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10683023
• 关键词: Acute; Address; Adult; Age; Ageism; Anxiety; Area; COVID-19 pandemic; Caring; Chronic Disease; County; Dementia; Drug usage; Elderly; Elements; Feeling; Future; Health; Health Services; Healthcare; Impaired cognition; Intervention; Interview; Knowledge; Learning; Link; Literature; Loneliness; Measures; Mental Depression; Mental Health; Methadone; Methods; Outcome; Participant; Patients; Pattern; Perception; Persons; Policy Maker; Population; Prevalence; Principal Investigator; Provider; Public Health; Recovery; Reporting; Research; Risk; Social Network; Social isolation; Substance Use Disorder; Time; Treatment outcome; addiction; adverse outcome; behavioral health; clinical care; experience; functional disability; health care service utilization; high risk; human old age (65+); implementation strategy; improved; interest; mortality risk; non-opioid analgesic; opioid treatment program; opioid use disorder; participant enrollment; patient population; physical conditioning; poor health outcome; protective factors; recruit; return to use; social; social contact; social stigma; study population; substance use

Project Summary/Abstract Older adults with substance use disorders are at high risk for associated adverse outcomes due to co-existing chronic diseases and functional impairments. This is also a population that has experienced a profound loss of their social networks and is therefore also at risk for social isolation and loneliness. Additionally, older adults with substance use disorder also experience a high level of stigma related to drug use, drug use treatment, and ageism. Recently, there has been increasing interest in the relationship between lack of social connectedness and stigma with health outcomes. Yet, very little research in this area has focused on older adults with substance use disorders. To address this, the objective of this research is to use the national expertise of the Principal Investigators (Drs. Han and Inagaki) to measure social isolation, loneliness, and intersectional stigma longitudinally among older adults who receive care in opioid treatment programs and examine how this may influence health outcomes. Aim 1 of this study is to characterize trajectories of social isolation and loneliness longitudinally. 150 older adults (age ³55) living with opioid use disorder who receive treatment in San Diego County’s opioid treatment programs will be recruited to complete validated measures of social isolation and loneliness at three-time points (baseline, 6 months, and 12 months later). Aim 2 will examine whether trajectories of social isolation and loneliness predict 12-month opioid use disorder treatment outcomes, non-opioid psychoactive substance use, and acute healthcare utilization. Finally, Aim 3, through qualitative interviews with a subset of enrolled participants (n=40), will explore patient perspectives on how social isolation and loneliness influence substance use, recovery, and treatment and elicit perspectives on strategies to address social connectedness through opioid treatment programs. As an exploratory aim, this study will measure the experienced stigma of this population through validated scales. During qualitative interviews, perspectives regarding stigma related to opioid use disorder, ageism, and other potentially related factors will also be assessed. Results from this research will ultimately inform future interventions to address isolation and disconnection among older adults with opioid use disorder. This will have additional public health implications for the efficacy of improving addiction treatment and health outcomes.

项目总结/摘要 患有物质使用障碍的老年人由于共存而面临相关不良后果的高风险 慢性疾病和功能障碍。这也是一个经历了深刻损失的人口， 他们的社交网络，因此也面临社会孤立和孤独的风险。此外，老年人 药物使用障碍患者也经历了与药物使用，药物使用治疗， 年龄歧视。近年来，人们越来越关注缺乏社会性的关系， 与健康结果的联系和耻辱。然而，这方面的研究很少集中在老年人身上。 患有物质使用障碍的成年人。为了解决这个问题，这项研究的目标是使用国家 主要研究者（Han博士和Inagaki博士）的专业知识，以衡量社会隔离，孤独， 在接受阿片类药物治疗计划的老年人中纵向交叉污名， 研究这可能如何影响健康结果。本研究的目的1是描述社会轨迹 孤独和寂寞。150名患有阿片类药物使用障碍的老年人（年龄≥ 55岁）， 圣地亚哥县阿片类药物治疗计划的治疗将被招募，以完成有效的措施， 在三个时间点（基线、6个月和12个月后）的社会孤立和孤独。目标2将 研究社交孤立和孤独的轨迹是否可以预测12个月的阿片类药物使用障碍治疗 结果、非阿片类精神活性物质使用和急性医疗保健利用。目标3，通过 定性访谈的一个子集的登记参与者（n = 40），将探讨病人的观点，如何 社会孤立和孤独影响物质使用，恢复和治疗，并引出对 通过阿片类药物治疗计划解决社会联系的战略。作为一个探索性的目标， 这项研究将通过经验证的量表来衡量这一群体经历过的耻辱。定性分析期间 访谈，关于与阿片类药物使用障碍，年龄歧视和其他潜在相关的耻辱的观点 还将评估各种因素。这项研究的结果最终将为未来的干预措施提供信息， 与阿片类药物使用障碍的老年人之间的隔离和断开。这将增加公共卫生 对改善成瘾治疗效果和健康结果的影响。